Mark Peakman
ORCID: 0000-0003-3328-3513Also affiliated with Sanofi (France), Sanofi (United States), Inflammation Research Foundation
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “HLA A*24:02–restricted T cell receptors cross-recognize bacterial and preproinsulin peptides in type 1 diabetes”.
Anna Bulek, Aaron Wall, Hannah Thomas, Jade R. Hopkins, Cristina Rius +21 more
Mario A. Cleves, Jay M. Sosenko, Ingrid Libman, David A. Baidal, Ashok Balasubramanyam +80 more
Zhicheng Zhou, Laurie G. Landry, A. Anderson, Aimon K. Alkanani, J Fischer +6 more
Iria Gómez-Touriño, Yogesh Kamra, Irma Pujol‐Autonell, Emily Hanton, Timothy Tree +8 more
Norkhairin Yusuf, Clara Domingo‐Vila, YF Liu, Polly J. Bingley, Mark Peakman +1 more
Clive Wasserfall, Alyssa Woodwyk, McKenzie Akers, Heather Rauch, Thomas M. Blok +7 more
Roman Baptista, Richard J. Ellis, Susanne Heck, Mark Peakman, Craig A. Beam +1 more